Magas vérnyomás: vizsgálatok itt: Japán
12 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Aira, Amagasaki-shi, Beppu-shi, Chigasaki-shi, Fujinomiya-shi, Hakodate-shi, Hamamatsu, Higashihiroshima-shi, Iizuka-shi, Inashiki-gun, Iwata-shi, Kagoshima, Kamakura-shi, Kanazawa, Kashiwara-shi, Kasugai-shi, Kita-ku, Kitakyushu, Kitakyushu-shi, Kobe, Kumagaya-shi, Kurashiki-shi, Kuse-gun, Kuwana-shi, Kyoto, Matsusaka-shi, Matsuyama, Meguro-ku, Minatoku, Minokamo Shi, Miyakonojo-shi, Morioka, Nagaoka-shi, Naka, Narita-shi, Obihiro-shi, Ōita, Ōme, Ōmihachiman, Osaka, Saga, Sapporo, Sendai, Shibuya-ku, tabashi City, Tanabe-shi, Toyoake-shi, Toyohashi, Tsu, Yaizu-shi, Yokohama, Yoshida-gun
- Életkor
- 18 év and over
- People
- 5000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - 3. fázisNot yet taking people in JapánA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
- Where
- Arakawa-ku, Tokyo, Okayama, Sendai-shi, Miyagi, Tokyo, Yamato-shi
- Életkor
- 18 év and over
- People
- 1408 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07919405 - 2. fázisTaking peopleA Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Where
- Hachiōji, Kamakura-shi, Naka, Narita
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07783802 - No phaseCsak meghívásosAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
- Where
- Kanagawa, Okinawa
- Életkor
- 0 Minutes to 2 hét
- People
- 8000 worldwide
- Run by
- Indiana University
See details and how to joinNCT06823115 - 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Aichi, Kariya, Aichi, Kasugai, Aichi, Nagoya, Chiba, Chiba, Chiba, Ichikawa, Chiba, Matsudo, Chiba, Narashino, Ehime, Matsuyama, Fukuoka, Chikushino, Fukuoka, Fukuoka, Gumma, Maebashi, Gumma, Takasaki, Hiroshima, Hiroshima, Hiroshima, Kure, Hokkaido, Asahikawa, Hokkaido, Sapporo, Hyogo, Nishinomiya, Ibaraki, Higashiibaraki-gun, Ibaraki, Mito, Ibaraki, Naka, Ibaraki, Tsukuba, Ishikawa, Kanazawa, Iwate, Morioka, Kagawa, Kanonji, Kagawa, Takamatsu, Kagoshima, Kagoshima, Kanagawa, Miura-gun, Kanagawa, Sagamihara, Kanagawa, Yokohama, Kochi, Kochi, Kumamoto, Kumamoto, Kumamoto, Kyoto, Kyoto, Miyagi, Sendai, Miyazaki, Miyakonojo, Nagano, Matsumoto, Nagasaki, Nagasaki, Okayama, Okayama, Osaka, Daito, Osaka, Matsubara, Osaka, Moriguchi, Osaka, Osaka, Osaka, Suita, Saitama, Ageo, Saitama, Koshigaya, Saitama, Saitama, Saitama, Tokorozawa, Shizuoka, Fujieda, Shizuoka, Sunto-gun, Tochigi, Shimotsuga-gun, Tochigi, Shimotsuke, Tokushima, Tokushima, Tokyo, Hachioji, Tokyo, Itabashi-ku, Tokyo, Minato-ku, Tokyo, Ota-ku, Toyama, Toyama, Toyoake-shi
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 3. fázisTaking peopleZilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Where
- Bunkyō City, Chikushino-shi, Chūōku, Fukuoka, Hachiōji, Hachioji-Shi, Hakodate-Shi, Hakusan, Himeji, Izumi, Kasuga, Kita-ku, Kusatsu, Minamiku, Minato, Nagaoka-Shi, Nagasaki, Okayama, Osaka, Ōta-ku, Saku, Sakura-Shi, Sapporo, Sendai, Shimotsuke-shi, Shinagawa-Ku, Shinjuku-Ku, Suita, Tamanashi, Yokohama, Yokosuka
- Életkor
- 18 év and over
- People
- 11 000 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07181109 · EU 2025-522960-34-00 - 1. fázisTaking peopleA Study of IBI3016 in Japanese Participants
- Where
- Osaka
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07838220 - 2. fázisTaking peopleAn Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Where
- Chuo Ku, Shinjuku Ku, Suita
- Életkor
- 18 év and over
- People
- 323 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07543120 - 1. fázisTaking peopleHJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension
- Where
- Sumida-ku
- Életkor
- 18 év to 60 év
- People
- 64
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07644364 - 1. fázisTaking peopleStudy of KK3910 in Healthy Volunteers and Patients With Essential Hypertension
- Where
- Hakata, Minato-ku, Yodogawa
- Életkor
- 18 év to 80 év
- People
- 160
- Run by
- Kyowa Kirin Co., Ltd.
See details and how to joinNCT06823947 - 4. fázisTaking peopleEffect of Dotinurad in Hyperuricemia With Hypertension
- Where
- Saga
- Életkor
- 20 év and over
- People
- 360
- Run by
- Saga University
See details and how to joinNCT06834230 - No phaseTaking peopleOsaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
- Where
- Sakai
- Életkor
- 20 év and over
- People
- 2000
- Run by
- Osaka Metropolitan University
See details and how to joinNCT06694012